Form 8-K - Current report:
SEC Accession No. 0000950170-24-124141
Filing Date
2024-11-08
Accepted
2024-11-08 16:25:20
Documents
13
Period of Report
2024-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20241108.htm   iXBRL 8-K 45080
2 EX-99.1 revb-ex99_1.htm EX-99.1 159250
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-24-124141.txt   394968

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20241108.xsd EX-101.SCH 49101
15 EXTRACTED XBRL INSTANCE DOCUMENT revb-20241108_htm.xml XML 6943
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 241440984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)